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To demonstrate the change in the expression of Angiotensin II type 1 receptor (AT1) in the 
rat bladder with partial bladder outlet obstruction (P-BOO) . 
Material and Methods 
Bladder specimens were obtained from twelve-week-old Wistar female rats that were 
divided two groups, a partial bladder outlet obstruction (P-BOO) group and a control group.  
The rats of the P-BOO group were divided into six groups; sham-operated control group, 1 
day postoperatively, 2 days postoperatively, 4 days postoperatively, 7 days postoperatively 
and 14 days postoperatively.  The cystometrical findings and immunohistochemical 
staining of the detrusor muscle with AT1 antibody was compared  in each group. 
Results 
AT1 localized on the cell membrane of the detrusor smooth muscle and in cytoplasm of 
suburothelial myofibroblasts in the control rats,.  The expression of AT1 disappeared in the 
detrusor muscle and suburothelial myofibroblasts in P-BOO, but, AT1 was highly expressed 
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in urothelial cells 1 day after surgery.  The expression of AT1 in urothelial cells gradually 
decreased with time after surgery.  AT1 completely disappeared in urothelial cells 14 days 
after surgery.  
Conclusions 
The present study demonstrated that the site of AT1 expression changes in response to the 
mechanical stress caused by P-BOO, and finally there was no expression of AT1 in rat 
bladder tissue following P-BOO.  These data suggest the change in AT1 expression may be 
play a role in bladder function.  
 
Introduction 
Angiotensin II (Ang II) is an important regulatory peptide with multiple physiological 
functions (1).  The main roles of Ang II are contractility, proliferation and fibrosis.  The 
local renin-angiotensin II system (RAS) has been demonstrated in various tissues, including 
the heart, kidney, adrenal, liver, blood vessels and gonads (2).  A few studies investigating 
the RAS and bladder function were reported in the 90’s.  They demonstrated that Ang II 
only has a weak contractive potential, and the blockade of the RAS has little influence on 
the bladder. 
Yamada et al. demonstrated that AT1 decreases in the rat bladder with incomplete 
urinary retention using a bladder outlet obstruction model, and stated that the cause might 
be down regulation of AT1 induced by the activation of RAS (3). 
This study investigated the changes of AT1 expression induced by BOO using 
immunohistochemistry.  
 
Materials and Methods 
Animals 
Adult female Wistar rats weighing 200–225 g and about 3 months of age were used in this 
study.  The study protocol was approved by the Animals Ethics Committee at Nagasaki 
University Graduate School of Biochemical Sciences, Japan.  The rats were housed at room 
temperature with humidity of about 65% and a 12:12 h light: dark cycle.  They had free 
access to water and commercial laboratory chow provided ad libitum.  These rats were 
divided into seven groups; a sham-operated control group, 1 day postoperatively, 2 days 
postoperatively, 4 days postoperatively, 7 days postoperatively and 14 days postoperatively. 
 
Partial Bladder Outlet Obstruction 
A modification of the technique of Mattiasson and Uvelius (4) and Malmgren (5) et al. was 
used to obtain a partial obstruction of the urethra.  The rats were anesthetized by 
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intraperitoneal injection of 1 g/kg body weight urethane.  The urethra was intubated with a 
PE-50 polyethylene catheter and a double 4-0 silk ligature was placed loosely around the 
proximal urethra producing a standardized degree of obstruction, and the catheter was 
removed.  The control rats underwent a sham operation.  
 
Immunohistochemical staining of AT1 
The bladder specimens were fixed with 4% paraformaldehyde in phosphate-buffered saline 
(PBS) and embedded in paraffin.  Sections were deparaffinized with xylene and 
sequentially rehydrated in a graded ethanol series for 5 min each. Endogenous peroxidase 
activity was blocked by incubation in 3% H2O2 in methanol for 15 min.  Sections were then 
incubated at 4°C for 24 hours with rabbit anti-AT1 receptor polyclonal antibody (Santa Cruz, 
Santa Cruz, CA) diluted 1:500 in phosphate-buffered saline.  The sections were washed and 
incubated with Histofine Simple Stain Rat Max-PO (Nichirei Co., Tokyo, Japan) for 30 min 
at room temperature.  The sections were stained with diaminobenzidine tetrahydrochloride 
(Nichirei Co., Tokyo, Japan), counterstained with hematoxylin, and mounted. 
 
Cystometric investigation 
The rats were anesthetized by intraperitoneal injection of 1 g/kg body weight 
urethane (6).  A PE-50 catheter was inserted through the bladder apex into the lumen and 
connected to a pressure transducer and a microinjection pump (UD5500, Dantec, Denmark).  
Warmed saline was then infused into the bladder at a rate of 10 mL/hr for the control and 
P-BOO rats, respectively.  
Results 
Cystometric investigation 
The voiding pattern in the control rats was normal.  The voiding frequency of the 
P-BOO rats at 1 day and 2 days were significantly greater than that of the control rats.  
The P-BOO rats at 14 days showed no detrusor contraction and voiding had the 
characteristics of overflow (Figure 3).  
 
Immunohistochemistry of AT1 
The localization of AT1 in the rat bladder was examined by immunocytochemistry.  
Figure 1 and 2 show the results of the immunohistochemistry.  AT1 immunoreactivity was 
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localized to smooth muscle cells and suburothelial myofibroblasts. AT1 immunostaining in 
the detrusor muscle was localized predominantly on the cell membrane and slightly in the 
cytoplasm (Figure 1, 2).  Replacement of the primary antibody with buffer also yielded 
negative staining (Figure 1, 2).  The expression of AT1 in the detrusor muscle and 
suburothelial myofibroblasts disappeared in P-BOO, but AT1 was highly expressed in 
urothelial cells at 1 day after surgery, (Figure 3).  The expression of AT1 in urothelial cells 
gradually decreased following surgery. There was no ATI immunostaining in the urothelial 
cells at 14 days after the surgery (Figure 3).  
 
Discussion 
The present study demonstrated the expression of AT1 on detrusor muscle cells and 
suburothelial myofibroblasts in the rat bladder.  Previous studies demonstrated that Ang II 
have a potential of contraction of rat bladder, these suggested that AT1 exist on rat bladder 
tissue.  Yamada et al. demonstrated that the expression of AT1 in the rat bladder decreases 
with bladder outlet obstruction using a sensitive binding assay (3).  The current data 
showed the reduction of AT1 expression caused by P-BOO visually and temporally using 
immunohistochemical staining.   Several investigators have shown that Ang II causes 
pronounced contraction of bladder smooth muscles in some species, including humans 
(7,8,9,10,11), and the effect is mediated by the AT1.  The down-regulation of AT1 in 
outlet-obstructed rat was observed by Saito et al. (12), who showed significantly weaker 
contractility of human detrusor muscle by Ang II in neurogenic bladders than controls.  
This suggests that the down-regulation of bladder AT1 is largely ascribable to the enhanced 
activity of Ang II following P-BOO.  Dinh et al. reported that dysuria caused by prostatic 
hyperplasia induces increased expression of Ang II and down-regulation of AT1 in human 
prostatic tissue (13).  The same phenomenon might occur in rat bladder tissue.  
Pathological conditions of the bladder might reduce expression of AT1, and this mechanism 
might be the cause of the reduced response of the human bladder to Ang II that Saito et al. 
reported.  Although the frequency of urination increased during the period of AT1 
expression in urothelial cells, the frequency of urination decreased after AT1 expression 
disappeared in urothelial cells.  AT1 was not expressed in  the urothelial layer without 
mechanical stress by P-BOO.  The current data demonstrated that AT1 expression in 
bladder tissue below the urothelium ceases and new expression of AT1 continues in the 
urothelium for a few days after acute incomplete urinary retention, and then AT1 gradually 
disappears from the urothelium.  The role of this phenomenon in bladder dysfunction is 
unknown; however, activated RAS within bladder tissue might induce frequent bladder 





The present study demonstrated that AT1 expression in the rat bladder does not 
uniformly disappear with mechanical stress by P-BOO.  The frequency of urination right 
after the induction of incomplete urinary retention might therefore be associated with the 
expression of AT1 in the urothelium for a short period of time.     
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Figure legends 
Figure 1.  Expression of AT1 on the detrusor muscle in the normal rat bladder.  (a) AT1 
expressed on the cell membrane of bladder smooth muscle.  (b)  Negative control  
Magnificarion ×600 
Figure 2.  Expression of AT1 in the suburothelial layer in the normal rat bladder.  (a) AT1 
expressed on suburothelial myofibroblasts. (b) Negative control  Magnificarion ×200 
Figure 3.  The changes of AT1 expression in bladder in response to P-BOO.  The 
expression of AT1 in urothelial cells gradually decreased.   
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